The Impact of Toll-like-receptor-9 on Intestinal Microbiota Composition and Extra-intestinal Sequelae in Experimental Toxoplasma Gondii Induced Ileitis

Overview

Journal Gut Pathog

Publisher Biomed Central

Specialty Gastroenterology

Date 2014 Jun 17

PMID 24932221

Citations 31

Authors

Stefan Bereswill

Anja A Kuhl

Marie Alutis

Andre Fischer

Luisa Mohle

Daniela Struck

Oliver Liesenfeld

Ulf B Gobel

Ildiko R Dunay

Markus M Heimesaat

Affiliations

Soon will be listed here.

Abstract

Background: Following peroral Toxoplasma (T.) gondii infection, susceptible mice develop acute ileitis due to a microbiota-dependent Th1 type immunopathology. Toll-like-receptor (TLR)-9 is known to recognize bacterial DNA and mediates intestinal inflammation, but its impact on intestinal microbiota composition and extra-intestinal sequelae following T. gondii infection has not yet been elucidated.

Methods And Results: Seven days following peroral infection (p.i.) with 100 cysts of T. gondii ME49 strain, TLR-9(-/-) and wildtype (WT) mice suffered from comparable ileitis, whereas ileal parasitic loads as well as IFN-γ and nitric oxide levels were higher in TLR-9(-/-) compared to WT mice. Locally, TLR-9(-/-) mice exhibited increased ileal CD3+, but not FOXP3+ cell numbers at day 7 p.i.; in mesenteric lymph nodes IFN-γ-producing CD4+ cell numbers and TNF-α and IFN-γ concentrations were also increased in TLR-9(-/-) compared to WT mice. T. gondii DNA levels, however, did not differ in mice of either genotype. Differences in intestinal microbiota were rather subtle except for bifidobacteria that were virtually absent in both, naïve and T. gondii infected TLR-9(-/-), but not WT mice. Extra-intestinally, TLR-9(-/-) mice displayed less distinct systemic immune responses as indicated by lower serum IL-6, and splenic TNF-α and IFN-γ levels as compared to WT mice despite higher translocation rates of intestinal bacteria to extra-intestinal compartments such as liver, spleen, kidney, and cardiac blood. Most importantly, brains were also affected in this inflammatory scenario as early as day 7 p.i. Remarkably, TLR-9(-/-) mice exhibited more pronounced inflammatory infiltrates with higher numbers of F4/80+ macrophages and microglia in the cortex and meninges as compared to WT mice, whereas T. gondii DNA levels did not differ.

Conclusion: We here show that TLR-9 is not required for the development of T. gondii induced ileitis but mediates distinct inflammatory changes in intestinal and extra-intestinal compartments including the brain.

Citing Articles

Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by infection.

Yang Z, Chen J, Zhang C, Peng H Front Microbiol. 2024; 15:1512233.

PMID: 39723133 PMC: 11668811. DOI: 10.3389/fmicb.2024.1512233.

Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?.

Prandovszky E, Severance E, Splan V, Liu H, Xiao J, Yolken R Front Cell Infect Microbiol. 2024; 14:1415079.

PMID: 39403206 PMC: 11471644. DOI: 10.3389/fcimb.2024.1415079.

P2X7 Receptor Modulation of the Gut Microbiota and the Inflammasome Determines the Severity of -Induced Ileitis.

Moreira-Souza A, Nanini H, Rangel T, da Silva S, Damasceno B, Ribeiro B Biomedicines. 2023; 11(2).

PMID: 36831091 PMC: 9952899. DOI: 10.3390/biomedicines11020555.

Parasite infections, neuroinflammation, and potential contributions of gut microbiota.

Alloo J, Leleu I, Grangette C, Pied S Front Immunol. 2022; 13:1024998.

PMID: 36569929 PMC: 9772015. DOI: 10.3389/fimmu.2022.1024998.

Persisting Microbiota and Neuronal Imbalance Following Infection Reliant on the Infection Route.

French T, Steffen J, Glas A, Osbelt L, Strowig T, Schott B Front Immunol. 2022; 13:920658.

PMID: 35898505 PMC: 9311312. DOI: 10.3389/fimmu.2022.920658.

References

Kim J, Kim N, Oh Y, Kim Y, Youn J, Ahn M . CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways. Int Immunol. 2005; 17(12):1525-31. DOI: 10.1093/intimm/dxh345. View

Wilson E, Wille-Reece U, Dzierszinski F, Hunter C . A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol. 2005; 165(1-2):63-74. DOI: 10.1016/j.jneuroim.2005.04.018. View

OMahony D, Murphy S, Boileau T, Park J, OBrien F, Groeger D . Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo. BMC Immunol. 2010; 11:63. PMC: 3016395. DOI: 10.1186/1471-2172-11-63. View

Naito Y, Takagi T, Kuroda M, Katada K, Ichikawa H, Kokura S . An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflamm Res. 2004; 53(9):462-8. DOI: 10.1007/s00011-004-1281-1. View

Munoz M, Heimesaat M, Danker K, Struck D, Lohmann U, Plickert R . Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med. 2009; 206(13):3047-59. PMC: 2806449. DOI: 10.1084/jem.20090900. View

Dunay I, DaMatta R, Fux B, Presti R, Greco S, Colonna M . Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 2008; 29(2):306-17. PMC: 2605393. DOI: 10.1016/j.immuni.2008.05.019. View

Andrade W, Souza M, Ramos-Martinez E, Nagpal K, Dutra M, Melo M . Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. Cell Host Microbe. 2013; 13(1):42-53. PMC: 3552114. DOI: 10.1016/j.chom.2012.12.003. View

Young G . Encephalopathy of infection and systemic inflammation. J Clin Neurophysiol. 2013; 30(5):454-61. DOI: 10.1097/WNP.0b013e3182a73d83. View

Dunay I, Heimesaat M, Bushrab F, Muller R, Stocker H, Arasteh K . Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother. 2004; 48(12):4848-54. PMC: 529229. DOI: 10.1128/AAC.48.12.4848-4854.2004. View

10.

Heimesaat M, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C . MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut. 2010; 59(8):1079-87. DOI: 10.1136/gut.2009.197434. View

11.

Butcher B, Fox B, Rommereim L, Kim S, Maurer K, Yarovinsky F . Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 2011; 7(9):e1002236. PMC: 3169547. DOI: 10.1371/journal.ppat.1002236. View

12.

Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N . Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A. 2004; 101(43):15416-21. PMC: 523464. DOI: 10.1073/pnas.0406933101. View

13.

Mennechet F, Kasper L, Rachinel N, Li W, Vandewalle A, Buzoni-Gatel D . Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J Immunol. 2002; 168(6):2988-96. DOI: 10.4049/jimmunol.168.6.2988. View

14.

Benson A, Pifer R, Behrendt C, Hooper L, Yarovinsky F . Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe. 2009; 6(2):187-96. PMC: 2746820. DOI: 10.1016/j.chom.2009.06.005. View

15.

Sartor R . Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010; 139(6):1816-9. DOI: 10.1053/j.gastro.2010.10.036. View

16.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

17.

Yarovinsky F . Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014; 14(2):109-21. DOI: 10.1038/nri3598. View

18.

Mohle L, Parlog A, Pahnke J, Dunay I . Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Eur J Microbiol Immunol (Bp). 2014; 4(1):65-75. PMC: 3955833. DOI: 10.1556/EuJMI.4.2014.1.6. View

19.

Vossenkamper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S . Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur J Immunol. 2004; 34(11):3197-207. DOI: 10.1002/eji.200424993. View

20.

Bereswill S, Fischer A, Plickert R, Haag L, Otto B, Kuhl A . Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011; 6(6):e20953. PMC: 3115961. DOI: 10.1371/journal.pone.0020953. View